Literature DB >> 26450911

Energy expenditure of transfemoral amputees during floor and treadmill walking with different speeds.

Inger Marie Starholm1, Peyman Mirtaheri2, Nihad Kapetanovic2, Tarjei Versto3, Gjermund Skyttemyr3, Fredrik Tobias Westby3, Terje Gjovaag4.   

Abstract

BACKGROUND: Walking energy expenditure, calculated as the percent utilization of the maximal aerobic capacity, is little investigated in transfemoral amputees.
OBJECTIVES: Compare the energy expenditure of healthy participants (control participants) and transfemoral amputees walking with their respective preferred walking speeds on the treadmill (TPWS) and floor (FPWS). STUDY
DESIGN: Randomized cross-over study.
METHODS: Oxygen uptake (VO2) was measured when walking with the FPWS and TPWS. VO2max was measured by an incremental treadmill test.
RESULTS: Mean ± standard deviation VO2max of the transfemoral amputees and control participants were 30.6 ± 8.7 and 49.0 ± 14.4 mL kg(-1) min(-1), respectively (p < 0.05). TPWS for the transfemoral amputees and control participants was 0.89 ± 0.2 and 1.33 ± 0.3 m s(-1), respectively (p < 0.01). FPWS for the transfemoral amputees and control participants was 1.22 ± 0.2 and 1.52 ± 0.1 m s(-1), respectively (p < 0.01). Walking on floor with the FPWS, the energy expenditure of the transfemoral amputees and control participants was 54% and 31% of VO2max, respectively (p < 0.01). Walking on the treadmill with the TPWS, the energy expenditure of the transfemoral amputees and control participants was 42% and 29% of the VO2max, respectively (p < 0.05).
CONCLUSION: Energy expenditure is higher for the transfemoral amputees than the control participants, regardless of walking surface. There are minimal differences in energy expenditure between treadmill and floor walking for the control participants but large differences for the transfemoral amputees. CLINICAL RELEVANCE: During walking, the transfemoral amputees expend a larger percentage of their maximal aerobic capacity than healthy participants. With a low VO2max, ordinary activities, such as walking, become physically more challenging for the transfemoral amputees than the control participants, and this may, in turn, have a negative effect on the walking range of the transfemoral amputees. © The International Society for Prosthetics and Orthotics 2015.

Entities:  

Keywords:  Gait; rehabilitation

Mesh:

Year:  2015        PMID: 26450911     DOI: 10.1177/0309364615588344

Source DB:  PubMed          Journal:  Prosthet Orthot Int        ISSN: 0309-3646            Impact factor:   1.895


  6 in total

1.  Moderate-to-Vigorous-Intensity Physical Activity Observed in People With Diabetes-Related Foot Ulcers Over a One-Week Period.

Authors:  Maggie Lee; Jaap J van Netten; Helen Sheahan; Peter A Lazzarini
Journal:  J Diabetes Sci Technol       Date:  2019-05-29

2.  Analysis of Continuously Varying Kinematics for Prosthetic Leg Control Applications.

Authors:  Kyle R Embry; Robert D Gregg
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2021-03-01       Impact factor: 3.802

3.  Metabolic costs of activities of daily living in persons with a lower limb amputation: A systematic review and meta-analysis.

Authors:  Loeke van Schaik; Jan H B Geertzen; Pieter U Dijkstra; Rienk Dekker
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

Review 4.  Preparing for snow-sport events at the Paralympic Games in Beijing in 2022: recommendations and remaining questions.

Authors:  K Fagher; J K Baumgart; G S Solli; H C Holmberg; J Lexell; Ø Sandbakk
Journal:  BMJ Open Sport Exerc Med       Date:  2022-02-22

5.  Interactions Between Transfemoral Amputees and a Powered Knee Prosthesis During Load Carriage.

Authors:  Andrea Brandt; Yue Wen; Ming Liu; Jonathan Stallings; He Helen Huang
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

Review 6.  Economic benefits of microprocessor controlled prosthetic knees: a modeling study.

Authors:  Christine Chen; Mark Hanson; Ritika Chaturvedi; Soeren Mattke; Richard Hillestad; Harry H Liu
Journal:  J Neuroeng Rehabil       Date:  2018-09-05       Impact factor: 4.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.